WHOOP Expands Advanced Labs with Specialized Blood Panels
Event summary
- WHOOP launched Specialized Panels, one-time blood tests analyzing 75–89 biomarkers across five health categories.
- Each panel costs $299, is FSA/HSA eligible, and does not require a subscription or prior Comprehensive Health Panel.
- Tests are performed by Quest Diagnostics at 2,000 U.S. locations, with results integrated into WHOOP’s app for personalized insights.
- Early data from Advanced Labs shows 22% of WHOOP’s active users exhibit metabolic dysfunction and 30% have cardiometabolic risks.
- WHOOP first entered blood biomarker testing in 2025 with Advanced Labs, combining wearable data with lab results.
The big picture
WHOOP’s expansion into specialized blood panels reflects the growing demand for personalized health insights beyond generic wellness tracking. By leveraging Quest Diagnostics’ lab infrastructure, WHOOP is positioning itself as a hybrid of wearable tech and diagnostic services, a trend accelerating in the health-tech sector. The company’s ability to monetize these targeted offerings without requiring subscriptions could broaden its revenue streams, though it faces competition from direct-to-consumer lab testing services.
What we're watching
- Market Differentiation
- Whether WHOOP can sustain competitive advantage through deeper health insights compared to broader wellness platforms.
- Adoption Pace
- The pace at which users adopt Specialized Panels, particularly among non-subscription members.
- Data Integration
- How effectively WHOOP integrates biomarker data with continuous wearable metrics to drive actionable health recommendations.
Related topics